Who
James N. Wilson
Director
Company insider
Files Form 4 as: Director, Corcept Therapeutics; Director, Amylin Pharmaceuticals.
In numbers
- Trades disclosed
- 240
- Buys
- 4
- Sells
- 43
- Bought
- $758K
- Sold
- $14.4M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 4 Oct 2005
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $762K6,654 at $114.48 | filing |
| 15 Oct 2026filed 16 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $351K3,046 at $115.39 | filing |
| 15 Oct 2026filed 16 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $35K300 at $116.30 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $750K6,800 at $110.27 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $44K400 at $110.84 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $313K2,800 at $111.70 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $750K6,800 at $110.27 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $44K400 at $110.84 | filing |
| 15 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $313K2,800 at $111.70 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $337K3,053 at $110.49 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $520K4,668 at $111.44 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $257K2,279 at $112.64 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $337K3,053 at $110.49 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $520K4,668 at $111.44 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $257K2,279 at $112.64 | filing |
| 15 Jul 2026filed 17 Jul 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $94K1,079 at $86.78 | filing |
| 15 Jul 2026filed 17 Jul 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $348K3,969 at $87.74 | filing |
| 15 Jul 2026filed 17 Jul 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $264K2,974 at $88.81 | filing |
| 15 Jul 2026filed 17 Jul 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $177K1,978 at $89.49 | filing |
| 15 Jul 2026filed 17 Jul 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $94K1,079 at $86.78 | filing |
News
No headline names them, or the companies they trade most, lately.